Free Trial

BioXcel Therapeutics (BTAI) Insider Trading & Ownership

→ The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad)
Free BTAI Stock Alerts
$2.85
+0.10 (+3.64%)
(As of 04/22/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

BioXcel Therapeutics (NASDAQ:BTAI) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
35.80%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$1.02 M
Get BTAI Insider Trade Alerts

Want to know when executives and insiders are buying or selling BioXcel Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BTAI Insider Buying and Selling by Quarter

Ad Wealthpin Pro
One trade. One ticker. One week.
Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week?
Well, then you should click here to see this free training.

BioXcel Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/4/2024Richard I SteinhartCFOSell1,069$2.63$2,811.47  
4/4/2024Vimal MehtaCEOSell5,268$2.62$13,802.16  
4/4/2024Vincent O'neillInsiderSell165$2.62$432.30  
6/15/2023Vimal MehtaCEOSell30,000$21.54$646,200.00  
5/22/2023Vimal MehtaCEOSell6,500$25.79$167,635.00  
5/15/2023Javier RodriguezInsiderSell1,785$27.32$48,766.20  
5/15/2023Richard I SteinhartCFOSell5,000$27.17$135,850.00  
(Data available from 1/1/2013 forward)

BTAI Insider Trading Activity - Frequently Asked Questions

Who is on BioXcel Therapeutics's Insider Roster?

The list of insiders at BioXcel Therapeutics includes Frank Yocca, Javier Rodriguez, Krishnan Nandabalan, Richard I Steinhart, Vimal Mehta, and Vincent O'neill. Learn more on insiders at BTAI.

What percentage of BioXcel Therapeutics stock is owned by insiders?

35.80% of BioXcel Therapeutics stock is owned by insiders. Learn more on BTAI's insider holdings.

Which BioXcel Therapeutics insiders have been selling company stock?

The following insiders have sold BTAI shares in the last 24 months: Frank Yocca ($1,519,394.65), Javier Rodriguez ($48,766.20), Krishnan Nandabalan ($2,029,310.26), Richard I Steinhart ($179,299.47), Vimal Mehta ($2,042,877.16), and Vincent O'neill ($432.30).

How much insider selling is happening at BioXcel Therapeutics?

Insiders have sold a total of 280,695 BioXcel Therapeutics shares in the last 24 months for a total of $5,820,080.04 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:BTAI) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
Banyan Hill Publishing
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
Traders Agency
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
[Shocking] Elon Musk’s Plan To End Banks
Crypto 101 Media
Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!
American Alternative